Lynne Hung, MD
Clinical Cardiac Electrophysiology · Mission Viejo, CANPI 1326004748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 386 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,412 and has fallen 50.4% since, to $1,196 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CA, where the typical reported total is $26,911.
Across 386 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$2K
- Boston Scientific$1K
- Johnson & Johnson$613
- Abbott$587
- Cardiva Medical, Inc.$586
- Biotronik Inc.$493
- plus $3K from 25 others
Across 17 payments — averaging $2743.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$45K
- Abbott$2K
What the payments were for
- Travel & lodging$2833%
- Food & beverage$7,67595%
- Education$1342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 60 | $1,837 |
| Boston Scientific | 37 | $1,464 |
| Johnson & Johnson | 70 | $613 |
| Abbott | 26 | $587 |
| Cardiva Medical, Inc. | 31 | $586 |
| Biotronik Inc. | 22 | $493 |
| E.r. Squibb & Sons, L.L.C. | 26 | $444 |
| Pfizer | 55 | $440 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $253 |
| Sanofi-aventis U.S. LLC | 11 | $242 |
| Medtronic | 6 | $203 |
| Cvrx, Inc. | 1 | $196 |
| Cook Medical LLC | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| AstraZeneca | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $60 |
| Amgen | 2 | $54 |
| Boehringer Ingelheim | 3 | $53 |
| Teleflex LLC | 2 | $51 |
| Chiesi USA, Inc. | 2 | $46 |
| Edwards Lifesciences | 1 | $36 |
| Lundbeck LLC | 2 | $34 |
| Cordis US CORP. | 1 | $25 |
| Novartis | 1 | $24 |
| Medline Industries LP | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
| Kestra Medical Technology Services, Inc. | 1 | $13 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $13 |
| Impulse Dynamics (USA) Inc. | 1 | $12 |
| Altathera Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,093 in reported general payments places this provider in the 20th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,210 | $1,237,953 |
| XareltoRivaroxaban | 1,119 | $1,183,783 |
| MultaqDronedarone Hcl | 42 | $55,810 |
| EntrestoSacubitril/Valsartan | 19 | $18,975 |
| Amiodarone Hcl | 669 | $16,418 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 36 | $11,476 |
| Flecainide Acetate | 323 | $10,579 |
| Dofetilide | 47 | $5,907 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 141 | $4,552 |
| Nebivolol Hcl | 87 | $4,539 |
| Metoprolol Succinate | 346 | $4,024 |
| SotalolSotalol Hcl | 269 | $3,786 |
| Losartan Potassium | 263 | $3,017 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $2,490 |
| Midodrine Hcl | 40 | $2,025 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $440 | $1,237,9531,210 claims |
| Johnson & JohnsonXarelto | $613 | $1,183,7831,119 claims |
| Sanofi-aventis U.S. LLCMultaq | $242 | $55,81042 claims |
| NovartisEntresto | $24 | $18,97519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in Mission Viejo
- Shephal DoshiSanta Monica$2.1M
- Jonathan HsuSan Diego$1.2M
- Leslie SaxonLos Angeles$1.1M
- Rahul BhardwajLoma Linda$935K
- Nicholas Olsonla Jolla$801K
- Jonathan DukesVentura$775K
- Brett GidneySanta Barbara$756K
- John Rogersla Jolla$738K
- Rajesh BankerNewport Beach$538K
- Rahul DoshiLos Angeles$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.